Pharma stocks showed strength on Thursday, defying market weakness. Dr Reddy’s Laboratories saw significant gains, fueled by anticipation of approval for its Semaglutide diabetes drug in Canada. Other pharma companies also experienced upward movement. This defensive sector appeal is attracting investors amid uncertain market conditions and geopolitical concerns.
Jupiter Wagons Q4 Results: Cons PAT tumbles 72% to Rs 29 crore, revenue falls 25% YoY
Jupiter Wagons saw its net profit drop 72% to Rs 29 crore in the March quarter. Revenue also fell 25% to Rs 780 crore. The